The original claim – weight neutral – was never true and they knew it wasn’t true, something that has ended up costing AstraZeneca $868 M plus legal fees so far [$520 M FDA-Fines + $198 M + $150 M]. The standard complaint is that they are getting off cheap, just a drop in the bucket compared to their profit margin – as if higher fines would deter such corporate behavior. Others feel that these things will continue until the actual executives involved in the deception are directly convicted of criminal behavior. But for the moment, AstraZeneca‘s Seroquel stands before us as the paradigm for how to play this game and win.
Saturday, February 26, 2011
1 Boring Old Man » selling seroquel V: driving the brand…
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment